OAKTREE CAPITAL MANAGEMENT LP - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is and the CUSIP is 29266SAA4. A total of 14 filers reported holding ENDOLOGIX INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q2 2017$3,814,000
-34.3%
4,000,000
-33.3%
0.06%
-26.2%
Q1 2017$5,808,000
+7.1%
6,000,0000.0%0.08%
+5.0%
Q4 2016$5,423,000
-37.7%
6,000,000
-33.3%
0.08%
-29.2%
Q3 2016$8,711,000
+280.1%
9,000,000
+267.9%
0.11%
+175.6%
Q2 2016$2,292,000
-23.3%
2,446,000
-18.5%
0.04%
-21.2%
Q2 2014$2,989,000
-55.2%
3,000,000
-57.1%
0.05%
-58.7%
Q1 2014$6,670,0007,000,0000.13%
Other shareholders
ENDOLOGIX INC shareholders Q1 2017
NameSharesValueWeighting ↓
Endurant Capital Management LP 1,541,000$1,498,0000.56%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,944,0000.16%
PALISADE CAPITAL MANAGEMENT, LP 2,874,000$2,793,0000.10%
ADVENT CAPITAL MANAGEMENT /DE/ 610,000$581,0000.01%
AMUNDI ASSET MANAGEMENT US, INC. 6,475,000$6,199,0000.01%
Citadel Advisors 4,080,000$3,953,0000.00%
Capco Asset Management, LLC 3,000$3,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 104,000$100,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 3,000$3,0000.00%
Bank of New York Mellon Corp 250,000$246,0000.00%
View complete list of ENDOLOGIX INC shareholders